Older woman with ovarian cancer have a worse prognosis compared to younger patients.
However, the reason is not known.
Currently, the standard of care is to evaluate younger and older pat ...

Condition: Ovarian Cancer

This research study is a Phase II clinical trial.
Phase II clinical trials test the effectiveness of an investigational drug, which is cisplatin in this trial, to learn how well it works in tr ...

Condition: Breast Cancer

This study is comparing the safety and effectiveness of abiraterone acetate alone, followed by the addition of prednisone (when the participant's disease worsens or the physician feels it would l ...

Condition: Castration-resistant Prostate Cancer

Background: Blinatumomab is a bispecific T-cell engager approved for the treatment of relapse/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL). Most studies evaluating blinatumomab were cond

Introduction: Compared to febrile neutropenia (FN), non-neutropenic fever (NNF) episodes in children with cancer have not been associated with severe outcomes. Risk factors for severe outcomes in FN a

Introduction: Steroid-refractory acute Graft-versus-Host Disease (SR-aGVHD) is a potentially fatal complication occurring in approximately 60-70% of severe grade III-IV GVHD cases, with a higher incid